Photocure ASA (OSL:PHO)
62.30
+0.10 (0.16%)
Aug 25, 2025, 3:43 PM CET
Photocure ASA Revenue
Photocure ASA had revenue of 135.62M NOK in the quarter ending June 30, 2025, a decrease of -6.76%. This brings the company's revenue in the last twelve months to 522.86M, up 1.81% year-over-year. In the year 2024, Photocure ASA had annual revenue of 525.39M with 4.94% growth.
Revenue (ttm)
522.86M
Revenue Growth
+1.81%
P/S Ratio
3.17
Revenue / Employee
5.23M
Employees
101
Market Cap
1.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 525.39M | 24.73M | 4.94% |
Dec 31, 2023 | 500.66M | 107.53M | 27.35% |
Dec 31, 2022 | 393.13M | 32.59M | 9.04% |
Dec 31, 2021 | 360.54M | 104.06M | 40.57% |
Dec 31, 2020 | 256.48M | -25.07M | -8.91% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 628.08M |
Nordhealth AS | 578.17M |
ArcticZymes Technologies ASA | 104.33M |
Vistin Pharma ASA | 452.25M |
Omda AS | 442.14M |
Gentian Diagnostics ASA | 163.38M |
Lytix Biopharma AS | 608.00K |
Nykode Therapeutics AS | 87.09M |